This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia | MicrobiomeTrials
← Back to trials NCT07277231
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia Recruiting PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-01-22Est. Completion: 2031-02
Enrollment target: 500 participantsLocations City of Hope National Medical Center, Duarte, California, United States Chao Family Comprehensive Cancer Center, Orange, California, United States Stanford Cancer Institute, Palo Alto, California, United States Rocky Mountain Cancer Centers (Williams) Usor, Aurora, Colorado, United States Mayo Clinic Jacksonville, Jacksonville, Florida, United States Mount Sinai Medical Center Braman Comprehensive Cancer Center, Miami, Florida, United States Moffitt Cancer Center, Tampa, Florida, United States Northwestern University, Chicago, Illinois, United States Midwestern Regional Medical Center, Zion, Illinois, United States Ochsner Clinic Foundation, New Orleans, Louisiana, United States Dana Farber Cancer Institute, Boston, Massachusetts, United States Mayo Clinic Rochester, Rochester, Minnesota, United States University of Nebraska Medical Center, Omaha, Nebraska, United States Columbia University Medical Center, New York, New York, United States Atrium Health Levine Cancer Institute (Lci), Charlotte, North Carolina, United States Other microbiome trials you might be interested in Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma
Chronic lymphocytic leukemia (CLL) is the most common leukemia in Western countries. The purpose of this study is to ass…
Duarte, United States Est. completion Jul 2027
B-cell Malignancy Marginal Zone Lymphoma Follicular Lymphoma Non-Hodgkin Lymphoma Waldenström Macroglobulinemia Chronic Lymphocytic Leukemia
Oncology Associates of Oregon Willamette Valley Cancer Center, Eugene, Oregon, United States
Upmc Hillman Cancer Center(Univ of Pittsburgh), Pittsburgh, Pennsylvania, United States
Texas Oncology Tyler, Tyler, Texas, United States
Huntsman Cancer Institute, Salt Lake City, Utah, United States
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Blacktown Cancer and Haematology Centre, Blacktown, New South Wales, Australia
Concord Repatriation General Hospital, Concord, New South Wales, Australia
Genesiscare North Shore, St Leonards, New South Wales, Australia
Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
Monash Health, Clayton, Victoria, Australia
Austin Health, Heidelberg, Victoria, Australia
Cabrini Hospital Malvern, Malvern, Victoria, Australia
The Alfred Hospital, Melbourne, Victoria, Australia
Instituto Dor de Pesquisa E Ensino Distrito Federal, Brasília, Brazil
Centro Gaucho Integrado de Oncologia Hospital Mae de Deus, Porto Alegre, Brazil
Ensino E Terapia de Inovacao Clinica Amo Etica, Salvador, Brazil
Instituto Dor de Pesquisa E Ensino Sao Paulo, São Paulo, Brazil
Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein, São Paulo, Brazil
Bc Cancer Victoria, Victoria, British Columbia, Canada
Juravinski Cancer Centre, Hamilton, Ontario, Canada
Ciusss Nim Hscm, Montreal, Quebec, Canada
Jewish General Hospital, Montreal, Quebec, Canada
Chu de Quebec Universite Laval, Hopital de Lenfant Jesus, Centre Integre de Cancerologie (Cic), Québec, Quebec, Canada
Ciusss de Lestrie Chus, Sherbrooke, Quebec, Canada
Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality, China
The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China
Sun Yat Sen University Cancer Center Huangpu Branch, Guangzhou, Guangdong, China
The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China
Guizhou Provincial Peoples Hospital, Guiyang, Guizhou, China
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
Henan Cancer Hospital, Zhengzhou, Henan, China
The Second Xiangya Hospital of Central South University, Changsha, Hunan, China
Jiangsu Province Hospital, Nanjing, Jiangsu, China
Affiliated Hospital of Nantong University, Nantong, Jiangsu, China
The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
The Second Affiliated Hospital of Xian Jiaotong University, Xi'an, Shaanxi, China
Shandong Provincial Hospital, Jinan, Shandong, China
Rui Jin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, China
Sichuan Academy of Medical Sciences and Sichuan Provincial Peoples Hospital, Chengdu, Sichuan, China
Institute of Hematology and Hospital of Blood Disease, Tianjin, Tianjin Municipality, China
First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
The First Affiliated Hospital, Zhejiang University School of Medicinechengzhan, Hangzhou, Zhejiang, China
Fakultni Nemocnice Brno, Brno, Czechia
Fakultni Nemocnice Hradec Kralove, Hradec Králové, Czechia
Fakultni Nemocnice Olomouc, Olomouc, Czechia
Fakultni Nemocnice Ostrava, Ostrava, Czechia
Fakultni Nemocnice Plzen, PLZE, Czechia
Vseobecna Fakultni Nemocnice V Praze, Prague, Czechia
Centre de Lutte Contre Le Cancer Institut Bergonie, Bordeaux, France
Chu Clermont Ferrand Therapie Cellulaire and Hematolo, ClermontFerrand, France
Centre Hospitalier Le Mans, Le Mans, France
Hopital Claude Huriez Chu Lille, Lille, France
Centre Leon Berard, Lyon, France
Chu Montpellier Hopital Saint Eloi, Montpellier, France
Iuc Toulouse Oncopole, Toulouse, France
Donauisar Klinikum Deggendorf Klinik Fur Onkologie Und Hamatologie, Deggendorf, Germany
Centrum Fur Haematologie Und Onkologie Bethanien, Frankfurt am Main, Germany
Geho Munster, Münster, Germany
Klinikum St Elisabeth Straubing Gmbh Mvz Klinikum Straubing Gmbh, Straubing, Germany
Irccs Azienda Ospedaliero Universitaria Bologna, Bologna, Italy
Aou Careggi, Servizio Sanitario Toscana, Florence, Italy
Ospedale San Raffaele, Milan, Italy
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan, Italy
Azienda Ospedaliera Di Padova, Padova, Italy
Fondazione Policlinico Universitario Agostino Gemelli, Roma, Italy
Flevoziekenhuis, Almere Stad, Netherlands
Albert Schweitzer Ziekenhuis, Dordrecht, Netherlands
Hagaziekenhuis, Sgravenhage, Netherlands
North Shore Hospital, Auckland, New Zealand
Auckland City Hospital, Auckland, New Zealand
Health New Zealand Canterbury, Christchurch, New Zealand
Dunedin Hospital, Dunedin, New Zealand
Wellington Regional Hospital (Ccdhb), Wellington, New Zealand
Szpital Specjalist W Brzozowie,Podkarpacki Osrodek Onkologiczny, Brzozów, Poland
Pratia Onkologia Katowice, Katowice, Poland
Pratia McM Krakow, Krakow, Poland
Uniwersytecki Szpital Kliniczny Nr 4 W Lublinie, Lublin, Poland
Uniwersytecki Szpital Kliniczny Im Jana Mikulicza Radeckiego We Wroclawiu, Wroclaw, Poland
Coltea Clinical Hospital, Bucharest, Romania
Institutul Clinic Fundeni, Bucureti, Romania
Institutul Oncologic Prof Dr Ion Chiricuta Cluj Napoca, ClujNapoca, Romania
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, South Korea
The Catholic University of Korea, Seoul St Marys Hospital, SeochoGu, Seoul Teugbyeolsi, South Korea
Severance Hospital Yonsei University Health System, SeodaemunGu, Seoul Teugbyeolsi, South Korea
Seoul National University Hospital, Seoul, Seoul Teugbyeolsi, South Korea
Asan Medical Center, SongpaGu, Seoul Teugbyeolsi, South Korea
Hospital Universitario Virgen de Las Nieves, Granada, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Spain
Hospital Clinico Universitario Virgen de La Arrixaca, Murcia, Spain
Karolinska Universitetssjukhuset Solna, Stockholm, Sweden
Queen Elizabeth Hospital, Birmingham, United Kingdom
University Hospitals Dorset Royal Bournemouth Hospital, Bournemouth, United Kingdom
St Jamess University Hospital, Leeds, United Kingdom
Kings College Hospital, London, United Kingdom
Norfolk and Norwich University Hospitals Nhs Foundation Trust, Norwich, United Kingdom Small Lymphocytic Lymphoma
Mantle Cell Lymphoma
Diffuse Large B Cell Lymphoma
Study consists of two main parts to explore tacabrutideg recommended dosing, a Phase 1 monotherapy dose finding comprise…
Birmingham, United States Est. completion Nov 2026